Amgen | AMGN - Net Income

Stock Price
279.08
Daily Change
-4.56 -1.61%
Monthly
-2.11%
Yearly
-14.35%
Q3 Forecast
281.29

Amgen reported $1.43B in Net Income for its fiscal quarter ending in June of 2025.




Net Income Change Date
AbbVie USD 938M 348M Jun/2025
Agios Pharmaceuticals USD -112020000 22.73M Jun/2025
ALKERMES USD 87.1M 64.63M Jun/2025
Amgen USD 1.43B 298M Jun/2025
Biogen USD 634.8M 394.3M Jun/2025
BioMarin Pharmaceutical USD 240.53M 54.85M Jun/2025
Bristol-Myers Squibb USD 1.31B 1.15B Jun/2025
Eli Lilly USD 5.66B 2.9B Jun/2025
Exelixis USD 230.42M 70.8M Jul/2025
Genmab DKK 336M 141M Jun/2025
Gilead Sciences USD 1.96B 645M Jun/2025
GlaxoSmithKline GBP 1.44B 181M Jun/2025
Glaxosmithkline GBP 1.44B 1.03B Jun/2025
Incyte USD 405M 246.8M Jun/2025
Ionis Pharmaceuticals USD 123.55M 270.49M Jun/2025
J&J USD 5.54B 5.46B Jun/2025
Merck USD 4.43B 652M Jun/2025
Moderna USD -825000000 146M Jun/2025
Neurocrine Biosciences USD 107.5M 99.6M Jun/2025
Novartis USD 4.02B 418M Jun/2025
Novartis USD 4.04B 1.22B Jun/2025
Pfizer USD 2.91B 58M Jun/2025
PTC Therapeutics USD -64849000 931.41M Jun/2025
Regeneron Pharmaceuticals USD 1.39B 582.9M Jun/2025
Roche Holding CHF 1.01B 2.12B Dec/2024
Sanofi EUR 3.94B 2.07B Jun/2025
Sarepta Therapeutics USD 196.89M 644.4M Jun/2025
Takeda JPY 124.24B 227.4B Jun/2025
Teva Pharmaceutical Industries USD 282M 68M Jun/2025
Ultragenyx Pharmaceutical USD -114951000 36.13M Jun/2025
Vertex Pharmaceuticals USD 1.03B 386.6M Jun/2025